The Defiance Daily Target 2X Short LLY ETF, trading under the ticker LLYZ, is a dynamic investment vehicle designed for those looking to capitalize on the inverse movements of Eli Lilly and Company's stock price. As a sector-focused exchange-traded fund, LLYZ zeroes in on the health care industry, specifically within the pharmaceuticals niche. This ETF is engineered to provide investors with a leveraged exposure that is twice the inverse of LLY's daily performance, minus fees and expenses, using sophisticated financial instruments such as swap agreements. By targeting the daily fluctuations of a major pharmaceutical player, LLYZ offers a strategic opportunity for investors seeking to hedge against or profit from downward trends in Eli Lilly's stock. It's an advanced tool for those with a keen understanding of market dynamics, offering a tactical approach to navigating the ever-evolving landscape of the health care sector.
Defiance Daily Target 2X Short LLY ETF (LLYZ) Fund Flow Chart
Defiance Daily Target 2X Short LLY ETF (LLYZ) 1 year Net Flows: 1000K
LLYZ ETF FAQ
What was LLYZ’s price range in the past 12 months?
LLYZ lowest ETF price was 18.44 and its highest was 20.57 in the past 12 months.
What is the AUM of LLYZ?
As of Sep 17, 2025 The AUM of LLYZ is 921.25K.
Is LLYZ overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does LLYZ pay dividends?
LLYZ does not currently pay dividends.
How many shares outstanding does LLYZ have?
Currently, no data Available
Which hedge fund is a major shareholder of LLYZ?
Currently, no hedge funds are holding shares in LLYZ